Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Digital Prime Technologies Expands its Talented Management Team with Appointment of Glen Garofalo as Head of Margin and Risk Solutions
-
Jushi Holdings Inc. Announces Participation in Upcoming Conferences and Events in April 2022
-
Jushi Holdings Inc. Announces Participation in Upcoming Conferences and Events in April 2022
-
Form SC 13G/A NAVIENT CORP Filed by: Cantor Fitzgerald Europe
-
NewLake Capital Partners to Participate in Upcoming Investor Conferences in April 2022
-
Cantor Fitzgerald Reiterates Pacific Biosciences of California (PACB) at Overweight, $23 PT, Corteva Collaboration Further Demonstrates Power of PACB's Hifi Technology
-
Cantor Fitzgerald Assumes Sarepta Therapeutics (SRPT) at Overweight
-
UPDATE: Cantor Fitzgerald Assumes PTC Therapeutics (PTCT) at Overweight
-
Westrock Coffee Company to Become Public Company Through Business Combination with Riverview Acquisition Corp. (RVAC)
-
Westrock Coffee Company, a Leading Integrated Coffee, Tea, Flavors, Extracts, and Ingredients Solutions Provider, to Become a Public Company Through Business Combination with Riverview Acquisition Cor
-
Curaleaf Announces April Investor Community Conference and Event Participation
-
Makor Group First in CME's Micro Ether Futures
-
Johnson & Johnson (JNJ) Estimates Lowered at Cantor Fitzgerald on Macro Headwinds
-
BancTrust & Co. Investment Bank Announces New Senior Hire to Fixed Income Trading Team
-
Bitcoin miner PrimeBlock to go public via $1.25 billion SPAC deal
-
Primeblock And 10X Capital Venture Acquisition Corp. II (VCXA) Announce Planned Merger
-
PRIMEBLOCK, AN INFRASTRUCTURE PROVIDER FOR BLOCKCHAIN TECHNOLOGY THAT MINES CRYPTOCURRENCIES, AND 10X CAPITAL VENTURE ACQUISITION CORP. II ANNOUNCE PLANNED MERGER
-
PRIMEBLOCK, AN INFRASTRUCTURE PROVIDER FOR BLOCKCHAIN TECHNOLOGY THAT MINES CRYPTOCURRENCIES, AND 10X CAPITAL VENTURE ACQUISITION CORP. II ANNOUNCE PLANNED MERGER
-
SELLAS Life Sciences (SLS) Prices 4.63M Shares at $5.40
-
SELLAS Life Sciences Announces Pricing of $25.0 Million Underwritten Public Offering
-
SELLAS Life Sciences (SLS) Announces Proposed Underwritten Public Offering
-
SELLAS Life Sciences Announces Proposed Underwritten Public Offering
-
GLOBAL SPAC PARTNERS ANNOUNCES MAILING OF ITS EXTENSION DEFINITIVE PROXY STATEMENT, SETTING A SHAREHOLDER MEETING ON APRIL 11, 2022, AND ENGAGEMENT OF CAPITAL MARKETS ADVISORS
-
GLOBAL SPAC PARTNERS ANNOUNCES MAILING OF ITS EXTENSION DEFINITIVE PROXY STATEMENT, SETTING A SHAREHOLDER MEETING ON APRIL 11, 2022, AND ENGAGEMENT OF CAPITAL MARKETS ADVISORS
-
Trevena (TRVN) PT Lowered to $2 at Cantor Fitzgerald
-
Auxly Cannabis (XLY:CN) (CBWTF) PT Lowered to Cdn$0.21 at Cantor Fitzgerald
-
Cutera (CUTR) PT Raised to $85 at Cantor Fitzgerald as AviClear Could Change Acne Paradigm
-
Trulieve Cannabis Corp (TCNNF) PT Lowered to $59 at Cantor Fitzgerald
-
Clarus (CRXT) PT Lowered to $3 at Cantor Fitzgerald
-
Form 10-K Cantor Fitzgerald Income For: Dec 31
-
Ric Kayne and Affiliates Confirm Nomination of Two Highly Qualified Candidates for Election to Athira Pharma’s Board of Directors
-
Satellogic (SATL) Elects Tom Killalea to its Board of Directors
-
Satellogic Elects Tom Killalea to its Board of Directors
-
Cantor Fitzgerald Lowers PT to $5, Reiterates Overweight Rating on PAVmed (PAVM)
-
PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
-
Cantor Fitzgerald Starts Nerdy (NRDY) at Overweight
-
Capricor Therapeutics to Participate in the Cantor Fitzgerald Rare Orphan Disease Summit
-
Cantor Fitzgerald Reiterates Overweight Rating and $12 PT on Lucid Diagnostics (LUCD), "We Encourage Investors to Acquire LUCD Shares at Attractive Valuation"
-
Jushi Holding (JUSHF) PT Lowered to $3.05 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Fortress Biotech (FBIO), Sees Upward Earnings Revisions and Multiple Expansion
-
Cantor Fitzgerald Reiterates Overweight Rating on Arcutis Biotherapeutics (ARQT)
-
Lucid Diagnostics Inc (LUCD) Provides Business Update, Reports Prelim Q4
-
Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results
-
UPDATE: Trulieve Cannabis Corp (TCNNF) PT Lowered to $60 at Cantor Fitzgerald
-
Abeona Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
-
Abeona Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
-
UPDATE: HUTCHMED (China) (HCM) and Viatris (VTRS) Top Cantor Fitzgerald's List of Biggest Short Interest Increases, Heron (HRTX) and Omeros (OMER) Continue to Have Higher Short Floats
-
Anavex Life Sciences to Participate in the Cantor Virtual Rare Orphan Disease Summit
-
Arcturus Therapeutics to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit
-
Cantor Fitzgerald Reiterates Overweight Rating on Graybug Vision (GRAY) with $4 PT, Believes Stock Deserves Greater Attention from Investors

